ClinVar Miner

Submissions for variant NM_000419.5(ITGA2B):c.2468G>A (p.Gly823Glu)

dbSNP: rs1166506747
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV001290475 SCV001478512 likely pathogenic Glanzmann thrombasthenia 2023-10-17 reviewed by expert panel curation The ITGA2B missense variant NM_000419.4:c.2468G>A replaces the glycine residue with a glutamic acid residue (p.Gly823Glu). This variant has been observed in a proband (PMID 25728920) with a phenotype specific for Glanzmann's thrombasthenia (PP4_strong) who also harbors a second ITGA2B variant (c.1413C>G, p.Tyr471Ter) previously classified by the VCEP as pathogenic (phase unconfirmed; PM3_supporting) . Furthermore, this variant has not been observed in population databases (absent from gnomAD v2.1.1 and v3; PM2_supporting) and the in silico meta-predictor REVEL score for this variant is 0.746 (above the VCEP-established threshold of 0.7; PP3). In summary, this variant is classified as likely pathogenic for autosomal recessive Glanzmann thrombasthenia. GT-specific criteria applied: PM2_supporting, PM3_supporting, PP3, and PP4_strong.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.